- Home
- ADAP vs MCHX Comparison
ADAP vs MCHX Comparison
Compare ADAP & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- MCHX
- Stock Information
- Founded
- ADAP 2008
- MCHX 2003
- Country
- ADAP United Kingdom
- MCHX United States
- Employees
- ADAP 506
- MCHX N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- MCHX Business Services
- Sector
- ADAP Health Care
- MCHX Consumer Discretionary
- Exchange
- ADAP Nasdaq
- MCHX Nasdaq
- Market Cap
- ADAP 75.5M
- MCHX 84.3M
- IPO Year
- ADAP 2015
- MCHX 2004
- Fundamental
- Price
- ADAP $0.29
- MCHX $1.39
- Analyst Decision
- ADAP Strong Buy
- MCHX
- Analyst Count
- ADAP 5
- MCHX 0
- Target Price
- ADAP $1.83
- MCHX N/A
- AVG Volume (30 Days)
- ADAP 777.8K
- MCHX 18.2K
- Earning Date
- ADAP 05-13-2025
- MCHX 05-13-2025
- Dividend Yield
- ADAP N/A
- MCHX N/A
- EPS Growth
- ADAP N/A
- MCHX N/A
- EPS
- ADAP N/A
- MCHX N/A
- Revenue
- ADAP $178,032,000.00
- MCHX $48,122,000.00
- Revenue This Year
- ADAP N/A
- MCHX $6.83
- Revenue Next Year
- ADAP $69.81
- MCHX N/A
- P/E Ratio
- ADAP N/A
- MCHX N/A
- Revenue Growth
- ADAP 195.34
- MCHX N/A
- 52 Week Low
- ADAP $0.20
- MCHX $1.23
- 52 Week High
- ADAP $1.48
- MCHX $2.40
- Technical
- Relative Strength Index (RSI)
- ADAP 51.38
- MCHX 42.07
- Support Level
- ADAP $0.30
- MCHX $1.26
- Resistance Level
- ADAP $0.32
- MCHX $1.50
- Average True Range (ATR)
- ADAP 0.02
- MCHX 0.11
- MACD
- ADAP 0.01
- MCHX 0.01
- Stochastic Oscillator
- ADAP 67.44
- MCHX 40.62
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.